PacificHealth Laboratories Inc
OTC:PHLI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (0.3), the stock would be worth $0 (0% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.3 | $0 |
0%
|
| 3-Year Average | 0.3 | $0 |
0%
|
| 5-Year Average | 0.3 | $0 |
0%
|
| Industry Average | 9.3 | $0 |
+2 859%
|
| Country Average | 14.4 | $0 |
+4 486%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
PacificHealth Laboratories Inc
OTC:PHLI
|
21 USD | 0.3 | -0 | |
| FR |
|
L'Oreal SA
PAR:OR
|
184.2B EUR | 17.1 | 30.1 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
92B GBP | 11.3 | 11.2 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.2T INR | 35.8 | 37.2 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.4B GBP | 13.2 | 18.8 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28.2B USD | 14.4 | -155.9 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
16.4B EUR | 8.2 | 17.4 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 10 | 22.6 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 37.3 | 62 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -6 373.4 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
783.4B INR | 31.5 | 43.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
PacificHealth Laboratories Inc
Glance View
PacificHealth Laboratories, Inc. engages in developing, marketing and selling of patented premium nutrition tools that enable its consumers to enhance their health, improve their performance and reach their athletic goals. The company is headquartered in Matawan, New Jersey and currently employs 8 full-time employees. The firm's principal area of focus is sports performance. The firm develops products that enhance hydration, fueling and muscle recovery. The firm's products include Endurox R4 Muscle Recovery Drink; Accelerade Protein Powered Sports Drink; Accel Gel All Natural Rapid Energy Gel; 2nd Surge; Endurox Excel; Accelerade Variety Pack, and Water Bottle. Its products are available in various flavors, which include tangy orange, fruit punch, lemon lime, chocolate, lemonade and double expresso.
